Overview
Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics
Status:
Unknown status
Unknown status
Trial end date:
2019-09-01
2019-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of the present study is to compare the effect of IV infusion 0.5 µg/kg dexmedetomidine and IV 0.1 mg/kg nalbuphine in preschool children for prevention of emergence agitation after adenotonsillectomy under sevoflurane anesthesia.Phase:
Phase 1/Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Ain Shams UniversityTreatments:
Dexmedetomidine
Nalbuphine
Criteria
Inclusion Criteria:- Children of (American Society of Anesthesiologist)ASA physical status grade I or II.
- Aged 2-5 years
- Undergoing elective adenotonsillectomy.
Exclusion Criteria:
- History of hypersensitivity to the studied drug.
- Refusal of the legal guardian to participate in the study.
- Severely agitated child at induction of anesthesia
- Occurrence of postoperative bleeding at(Post Anesthesia Care Unit) PACU